市場調查報告書
商品編碼
1014880

大腸癌症治療藥的全球市場:COVID-19的影響·復甦之路 (∼2030年)

Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球大腸癌症治療藥的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,類型·通路·級·地區/主要國家等各種區分的明細,競爭環境,主要企業的簡介,成長機會,各種建議等資料。

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢·市場策略

第4章 COVID-19的影響

第5章 市場分析·預測

  • 市場規模的轉變·預測
  • 市場成長的促進因素
  • 市場阻礙成長要素

第6章 市場分析·預測:各種區分

  • 各類型
  • VEGF抑制劑
  • EGFR抑制劑
  • PD1/PDL1抑制劑
  • BRAF·MEK抑制劑
  • 蛋白酪氨酸激酶(TKI)抑制劑
  • 免疫調節劑
  • 各銷售管道
  • 醫院藥局
  • 零售藥局
  • 其他
  • 各級
  • 免疫療法
  • 化療
  • 其他

第7章 市場分析·預測:各地各國

第8章 亞太地區市場分析·預測

  • 市場概要
  • 地區資訊·COVID-19的影響·市場資訊·背景資訊·政府措施·法律規章·機關&協會·租稅·投資·主要企業
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第9章 中國市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第10章 印度市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第11章 日本市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第12章 澳洲市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第13章 印尼市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第14章 韓國市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第15章 西歐市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第16章 英國市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第17章 德國市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第18章 法國市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第19章 東歐市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第20章 俄羅斯市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第21章 北美市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第22章 美國市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第23章 南美市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第24章 巴西市場分析·預測

  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第25章 中東市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第26章 非洲市場分析·預測

  • 市場概要
  • 市場分析·預測:各類型
  • 市場分析·預測:各銷售管道

第27章 競爭情形·企業簡介

  • 競爭情形
  • 企業簡介
    • Merck & Co. Inc
    • Roche
    • Sanofi
    • Amgen
    • PFIZER, INC.

第28章 開發平台分析

第29章 M&A

第30章 未來展望·潛在性分析

第31章 附錄

目錄

Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global colorectal cancer drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the colorectal cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Colorectal Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors; Epidermal Growth Factor Receptor (EGFR) Inhibitors; Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors; BRAF or MEK Inhibitors; Tyrosine Kinase (TKI) Inhibitors; Immunomodulators

2) By Distribution Channels: Hospitals Pharmacies; Retail Pharmacies; Others

3) By Class: Immunotherapy; Chemotherapy; Others

Companies Mentioned: Merck & Co. Inc; Roche; Sanofi; Amgen; PFIZER

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Drugs Market Characteristics

3. Colorectal Cancer Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Colorectal Cancer Drugs

5. Colorectal Cancer Drugs Market Size And Growth

  • 5.1. Global Colorectal Cancer Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Colorectal Cancer Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Colorectal Cancer Drugs Market Segmentation

  • 6.1. Global Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Vascular Endothelial Growth Factor (VEGF) Inhibitors
  • Epidermal Growth Factor Receptor (EGFR) Inhibitors
  • Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
  • BRAF or MEK Inhibitors
  • Tyrosine Kinase (TKI) Inhibitors
  • Immunomodulators
  • 6.2. Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • 6.3. Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Immunotherapy
  • Chemotherapy
  • Others

7. Colorectal Cancer Drugs Market Regional And Country Analysis

  • 7.1. Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Colorectal Cancer Drugs Market

  • 8.1. Asia-Pacific Colorectal Cancer Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Colorectal Cancer Drugs Market

  • 9.1. China Colorectal Cancer Drugs Market Overview
  • 9.2. China Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Colorectal Cancer Drugs Market

  • 10.1. India Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Colorectal Cancer Drugs Market

  • 11.1. Japan Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Colorectal Cancer Drugs Market

  • 12.1. Australia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Colorectal Cancer Drugs Market

  • 13.1. Indonesia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Colorectal Cancer Drugs Market

  • 14.1. South Korea Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Colorectal Cancer Drugs Market

  • 15.1. Western Europe Colorectal Cancer Drugs Market Overview
  • 15.2. Western Europe Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Colorectal Cancer Drugs Market

  • 16.1. UK Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Colorectal Cancer Drugs Market

  • 17.1. Germany Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Colorectal Cancer Drugs Market

  • 18.4. France Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Colorectal Cancer Drugs Market

  • 19.1. Eastern Europe Colorectal Cancer Drugs Market Overview
  • 19.2. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Colorectal Cancer Drugs Market

  • 20.1. Russia Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Colorectal Cancer Drugs Market

  • 21.1. North America Colorectal Cancer Drugs Market Overview
  • 21.2. North America Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Colorectal Cancer Drugs Market

  • 22.1. USA Colorectal Cancer Drugs Market Overview
  • 22.2. USA Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Colorectal Cancer Drugs Market

  • 23.1. South America Colorectal Cancer Drugs Market Overview
  • 23.2. South America Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Colorectal Cancer Drugs Market

  • 24.1. Brazil Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Colorectal Cancer Drugs Market

  • 25.1. Middle East Colorectal Cancer Drugs Market Overview
  • 25.2. Middle East Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Colorectal Cancer Drugs Market

  • 26.1. Africa Colorectal Cancer Drugs Market Overview
  • 26.2. Africa Colorectal Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Colorectal Cancer Drugs Market Competitive Landscape
  • 27.2. Colorectal Cancer Drugs Market Company Profiles
    • 27.2.1. Merck & Co. Inc
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Roche
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Sanofi
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Amgen
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. PFIZER, INC.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Colorectal Cancer Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market

30. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer